Stay updated on L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page.

Latest updates to the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.8.0 to v3.8.1. The study record content is unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedThe 403 page is replaced by the study record for the L-DOS47 lung adenocarcinoma trial, with its design, eligibility criteria, locations, outcomes, and terminated status displayed.SummaryDifference51%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA sitewide NIH transition announcement appears above the 403 error page, and the footer revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible.SummaryDifference1%

- Check45 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page remains a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error with a basic Home link, indicating access to the record is blocked rather than showing study details.SummaryDifference19%

- Check65 days agoChange DetectedRevision label on the page was updated from v3.6.6 to v3.7.0, indicating a newer version of the page content.SummaryDifference0.1%

Stay in the know with updates to L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page.